{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-26-115723","form_type":"8-K","ticker":"UTHR","cik":"0001082554","company_name":"UNITED THERAPEUTICS Corp","filed_at":"2026-10-14T11:00:31+00:00","discovered_at":"2026-10-14T11:05:00.181384+00:00","generated_at":"2026-10-14T11:05:11.397265+00:00","sec_items":["8.01","9.01"],"event_type":"litigation","sentiment":"positive","materiality_score":0.78,"calibrated_materiality_score":0.78,"confidence":"high","headline":"UT settles Liquidia patent suits: $330.4M inflow, Yutrepia PH-ILD label removal","bullets":["Liquidia to pay UT $330.4M: $185M within 30 business days for past Yutrepia PH-ILD sales, plus $145.4M in two $72.7M installments due Jan 31 and Apr 30, 2027.","UT to pay Liquidia $10M to settle the RareGen/Sandoz antitrust case; Liquidia must obtain Sandoz consent to secure dismissal.","Liquidia must file an FDA amendment stripping the PH-ILD indication from Yutrepia's label, halt PH-ILD promotion/detailing, and end ASCENT PH-ILD trial cohorts.","Third Circuit on Oct 7, 2026 affirmed UT on antitrust claims, reversed Sandoz's $61.6M breach-of-contract award, and revived the tortious interference claim.","UT's '327 patent runs to Feb 3, 2042; trade-secret claims against former Liquidia executive Dr. Robert Roscigno survive the settlement."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-26-115723","json":"https://secwatch.observer/filing/0001104659-26-115723.json","markdown":"https://secwatch.observer/filing/0001104659-26-115723.md","text":"https://secwatch.observer/filing/0001104659-26-115723.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1082554/000110465926115723/0001104659-26-115723-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1082554/000110465926115723/tm2627546d1_8k.htm"},"model":{"generated_by":"deepseek-v4.1-flash:cloud@v2","generated_at":"2026-10-14T11:05:11.397265+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}